Overview of Xifaxan

Xifaxan is a brand-name medicine that contains rifaximin, an antibiotic designed to act primarily within the gut. It is commonly discussed in gastroenterology because it tends to have limited absorption into the bloodstream compared with many other antibiotics. This local activity profile is one reason clinicians consider it for certain intestinal conditions where targeting bacteria in the bowel is relevant. As with any prescription medicine, appropriate use depends on the diagnosis, medical history, and local regulatory requirements in Denmark.

Unlike broad systemic antibiotics used for infections throughout the body, Xifaxan is intended for specific, evidence-based indications tied to the gastrointestinal tract. Its benefits and risks can differ depending on the condition being treated and the dose used. Because symptoms such as diarrhea, bloating, abdominal pain, or confusion can have multiple causes, it is important not to assume Xifaxan is suitable without proper assessment. This page provides general education and purchasing guidance and does not replace individualized medical advice.

When considering Xifaxan from an online pharmacy, focus on product authenticity, clear labeling, and the availability of pharmacist support. Reliable providers typically offer transparent information about the manufacturer, batch/expiry details, and delivery logistics. They also set clear expectations about whether a prescription is required and what verification steps may be needed. This approach supports safer use and aligns with patient-protection standards.

Active Ingredient and What It Is Used For

The active ingredient in Xifaxan is rifaximin, a rifamycin-class antibiotic. It is used for certain conditions where altering or reducing specific intestinal bacteria can improve symptoms or reduce recurrence. Commonly referenced uses include traveler’s diarrhea caused by noninvasive strains of Escherichia coli, reduction of recurrence risk of hepatic encephalopathy in eligible patients, and treatment of irritable bowel syndrome with diarrhea (IBS-D) in some jurisdictions. The exact approved uses can vary by country and product labeling, so Danish authorization and local prescribing norms matter.

For traveler’s diarrhea, the goal is typically to shorten symptom duration in carefully selected cases. For hepatic encephalopathy, rifaximin may be used as ongoing therapy in people with liver disease to reduce the chance of recurrent episodes, often alongside other treatments such as lactulose when clinically appropriate. For IBS-D, rifaximin is sometimes used as a time-limited course in selected adults, particularly when symptoms suggest a gut-microbiome component. A clinician should evaluate red flags such as fever, blood in stool, dehydration, or severe abdominal pain before any antibiotic is considered.

It is not appropriate for every type of diarrhea or gastrointestinal complaint. Antibiotics generally do not help viral gastroenteritis and may worsen certain infections or contribute to antibiotic resistance. If you suspect food poisoning with high fever, persistent vomiting, or signs of invasive infection, prompt medical evaluation is recommended. For chronic symptoms, assessment for inflammatory bowel disease, malabsorption, and other causes is important before treatment decisions.

History, Origin, and Development

Rifaximin belongs to the rifamycin family, a class of antibiotics derived from earlier discoveries that targeted bacterial RNA synthesis. The development path for rifaximin focused on creating an agent that would act mainly in the intestinal lumen, aiming to limit systemic exposure while still providing antibacterial activity where needed. This design concept helped differentiate it from antibiotics intended to treat widespread systemic infections. Over time, clinical research expanded its role in specific gastrointestinal and liver-related indications.

The brand Xifaxan became widely recognized as clinical trials and real-world practice clarified which patient populations may benefit most. In particular, its role in reducing recurrence of hepatic encephalopathy contributed to broader awareness in hepatology. Its potential in IBS-D also increased public interest, especially among patients seeking options beyond diet modification and symptomatic therapies. As with many medicines, adoption has been shaped by guideline updates, local approvals, and evolving evidence.

Despite being an antibiotic, rifaximin’s targeted gut activity has driven a distinct safety and stewardship discussion. Clinicians still weigh the benefits against concerns such as resistance and microbiome changes, even when systemic absorption is low. This balance is part of why many countries keep it as a prescription medicine and why patient selection remains central. Understanding this context can help patients set realistic expectations and use the product responsibly.

Mechanism of Action (How Xifaxan Works)

Rifaximin works by inhibiting bacterial RNA synthesis through binding to the beta-subunit of bacterial DNA-dependent RNA polymerase. This prevents bacteria from producing essential RNA and proteins, limiting their growth and ability to persist. Because rifaximin is minimally absorbed in many individuals, much of its activity occurs within the gastrointestinal tract. This localized mechanism supports its use in conditions where intestinal bacteria are a key contributor.

In traveler’s diarrhea caused by susceptible noninvasive bacteria, reducing the bacterial load may help shorten symptoms. In hepatic encephalopathy, one therapeutic concept is that reducing ammonia-producing gut bacteria can lower neurotoxin production, potentially decreasing recurrence risk. In IBS-D, the mechanism is not fully simplified to one pathway, but symptom improvement may relate to changes in gut microbial patterns and downstream effects on gas production and gut signaling. Individual response can vary, and not all patients benefit equally.

Even with primarily local gut activity, antibiotics can influence the microbiome broadly. Some people experience changes in bowel habit, and there is still a risk of antibiotic-associated diarrhea. A history of Clostridioides difficile infection or significant comorbidity may require extra caution. Discussing prior antibiotic reactions and gastrointestinal history with a clinician or pharmacist can improve safety.

How to Take Xifaxan Safely

Xifaxan should be taken exactly as directed on the product label or by a prescriber. Dosing schedules differ by indication, and it is important not to swap regimens intended for one condition to treat another. Tablets are typically swallowed with water, and many patients can take rifaximin with or without food, depending on labeling and clinical guidance. Completing the prescribed course is important unless a clinician advises stopping due to adverse effects.

If a dose is missed, many standard instructions advise taking it when remembered unless it is close to the next scheduled dose. Doubling up is generally discouraged because it may increase side effects without improving outcomes. If symptoms worsen, do not improve as expected, or new symptoms appear, medical review is appropriate. For diarrhea, signs of dehydration or blood in stool warrant timely evaluation.

Antibiotic stewardship matters even for gut-targeted agents. Using Xifaxan only when appropriate helps reduce resistance and preserves effectiveness. Avoid sharing antibiotics with others or saving leftover tablets for future episodes. For long-term indications such as hepatic encephalopathy risk reduction, follow-up and monitoring plans should be discussed with a healthcare professional.

Available Forms, Strengths, and Typical Courses

Xifaxan is commonly supplied as oral tablets, and in many markets a frequently seen strength is 550 mg, though availability can vary by country. Some settings also use other strengths such as 200 mg depending on indication and local product lines. The exact presentation sold in Denmark may depend on marketing authorization, supply, and distributor agreements. Always check the outer packaging and patient leaflet for the strength and directions.

Course length depends on the clinical purpose. Short, time-limited regimens may be used for conditions like traveler’s diarrhea or IBS-D when indicated, while longer-term therapy may be considered for reducing recurrence of hepatic encephalopathy in selected patients. Do not assume that a longer duration is better; unnecessary exposure can increase side effects and resistance risk. Your clinician should weigh benefits, previous responses, and other therapies when determining duration.

Below is a practical overview of what patients should verify before starting a course. The aim is to reduce common medication errors such as taking the wrong strength or mixing up regimens. If anything on the label conflicts with your instructions, contact a pharmacist before taking the first dose.

• Confirm the exact tablet strength and the total number of tablets provided.
• Confirm the dosing schedule (times per day) and total duration.
• Check expiry date, storage instructions, and intact blister packaging.
• Review the leaflet for contraindications and warning signs requiring urgent care.

Effects: Onset, Duration, and Time to Leave the Body

How quickly Xifaxan helps depends on the condition being treated and the underlying cause of symptoms. For acute diarrhea caused by susceptible bacteria, some people notice improvement within a couple of days, while others may need longer or may not respond if the cause is viral or invasive. For IBS-D, symptom change may be gradual and may occur over days to weeks depending on the regimen used. For hepatic encephalopathy prevention, the goal is often reducing recurrence risk over time rather than producing an immediate noticeable effect.

The duration of effect also varies. In some cases, benefits may persist beyond the dosing period, while in others symptoms may return, requiring reassessment. Recurrence can indicate that the original diagnosis needs review or that other contributors such as diet, comorbid disease, or medications are involved. Repeated courses should only be undertaken under appropriate clinical guidance.

Regarding how long it takes to leave the body, rifaximin is generally considered minimally absorbed and primarily eliminated through the gastrointestinal tract. Because of this, the concept of “clearance” differs from systemically absorbed drugs; much of the medicine is present in the gut and then passes with stool. Any absorbed fraction is typically eliminated over time, but individual factors like liver function and concomitant medicines can matter. If you need medicine-timing advice for procedures or other therapies, consult a clinician or pharmacist for individualized guidance.

Scientific Evidence and What Research Generally Shows

Scientific interest in rifaximin has focused on conditions where the gut microbiome and bacterial products influence symptoms or complications. Clinical trials and practice guidelines in various regions have evaluated rifaximin for traveler’s diarrhea due to specific bacteria, for reduction of recurrent hepatic encephalopathy episodes in suitable patients, and for IBS-D in selected adults. The strength of evidence differs by indication and population, so “works for everyone” claims are not appropriate. Real-world outcomes depend on diagnosis accuracy, adherence, and comorbidities.

For hepatic encephalopathy, evidence has supported its use in reducing recurrence risk when used as part of a broader management plan. In IBS-D, research suggests some patients can achieve meaningful symptom relief, though responses vary and repeat treatment strategies should be clinician-directed. For acute infectious diarrhea, careful selection is critical because invasive pathogens may require different management. Ongoing research continues to examine microbiome effects, resistance patterns, and optimal patient selection.

When reading about studies online, prioritize reputable medical sources and pay attention to the studied indication, dose, and patient characteristics. Outcomes in one subgroup may not apply to another, and marketing summaries can omit limitations. If you have complex medical history—especially liver disease, recurrent infections, or immune compromise—professional guidance is particularly important. A pharmacist can help interpret product labeling and general evidence in a patient-friendly way.

Dependence, Misuse Potential, and Antibiotic Resistance

Xifaxan is not considered an addictive medication and does not typically cause dependence in the way that opioids, benzodiazepines, or stimulants can. It does not produce a classic intoxication effect, and withdrawal syndromes are not expected. However, any medicine can be misused if taken without a valid indication or repeatedly without appropriate oversight. The main public health concern with inappropriate antibiotic use is the development of resistance.

Resistance can occur when bacteria adapt, making future infections harder to treat. Even with relatively gut-focused antibiotics, resistant organisms can emerge in the intestinal flora and potentially spread. This is one reason many health systems emphasize antibiotic stewardship and reserve specific antibiotics for evidence-based uses. Taking Xifaxan only as prescribed and avoiding unnecessary repeat courses supports both individual and community health.

If you find yourself repeatedly seeking antibiotics for recurring symptoms, consider a structured medical review rather than self-treatment. Recurrent diarrhea, bloating, or abdominal discomfort can reflect dietary intolerance, inflammatory disease, bile acid diarrhea, medication effects, or other conditions. Treating symptoms with repeated antibiotics may delay the correct diagnosis. A clinician can help set a plan that may include testing, diet strategies, and safer long-term options.

Side Effects and What to Watch For

As with all medicines, Xifaxan can cause side effects, though not everyone experiences them. Commonly reported effects include gastrointestinal symptoms such as nausea, abdominal discomfort, or changes in bowel habits. Headache and fatigue have also been reported in some patients. Because underlying conditions can cause similar symptoms, it is important to consider timing relative to starting the medicine.

More serious reactions are less common but require prompt attention. Severe or persistent diarrhea—especially if watery, frequent, or accompanied by fever—should be evaluated to rule out antibiotic-associated colitis, including C. difficile infection. Any signs of allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing, should be treated as urgent. If you have liver disease, report any worsening confusion, drowsiness, or changes in mental status promptly.

If side effects occur, do not attempt to self-manage by adding multiple over-the-counter products without advice, especially antidiarrheals when infection is suspected. A pharmacist can help you decide whether symptoms are expected and manageable or whether you should stop the medicine and seek assessment. Reporting side effects also supports medication safety monitoring. Keep a list of all current medicines and supplements so interactions and additive effects can be considered.

Who Should Not Take Xifaxan (Contraindications and Restrictions)

Xifaxan may not be suitable for everyone. People with known hypersensitivity to rifaximin or related rifamycin antibiotics should avoid it due to risk of allergic reactions. Certain types of diarrhea, particularly when caused by invasive pathogens that can produce fever or bloody stools, may require different evaluation and treatment. If symptoms suggest systemic infection, an antibiotic with broader systemic activity may be needed under medical supervision.

Patients with severe liver impairment should use caution and follow clinician guidance, because changes in absorption and exposure may occur. While rifaximin is often used in liver disease for hepatic encephalopathy prevention, dosing and monitoring should follow established medical direction. Individuals with significant comorbidities, immunosuppression, or recent hospitalization should also seek professional advice before using any antibiotic. These factors can change both risks and expected benefits.

Pregnancy and breastfeeding considerations should be discussed with a healthcare professional, since risk-benefit decisions depend on the indication and available safety information. Do not assume safety based on low absorption alone. If you are planning pregnancy, breastfeeding, or have a child who may need treatment, a clinician should confirm suitability. Medication decisions in these contexts should be personalized and cautious.

Age Limits and Special Populations

Age restrictions for Xifaxan depend on the indication and local labeling in Denmark. Some uses are intended for adults, and pediatric use, if any, requires specific dosing, safety evidence, and medical supervision. For older adults, considerations include comorbidities, concurrent medications, and vulnerability to dehydration from diarrhea. A careful review of risks and benefits is important, especially when symptoms are severe or persistent.

For children and adolescents with diarrhea, the cause may differ from adults, and dehydration risk can escalate quickly. This makes self-treatment with antibiotics particularly unsuitable without medical input. For IBS-like symptoms in younger people, evaluation for other conditions may be needed before any antibiotic is considered. Always consult a clinician for age-appropriate care.

For patients with chronic liver disease, management plans often include multiple therapies, dietary adjustments, and monitoring. Adding or changing medicines without oversight can destabilize symptoms. If Xifaxan is part of a long-term plan, adherence and follow-up are key. A pharmacist can assist with practical strategies such as medication calendars and refill synchronization.

Drug Interactions, Alcohol, and Allergy Considerations

Rifaximin has fewer systemic interactions than many antibiotics because it is often minimally absorbed, but interactions are still possible. Always disclose prescription medicines, over-the-counter products, and supplements to your pharmacist. Particular caution may be warranted with medicines that have a narrow therapeutic index or when liver disease alters drug handling. If you are unsure, seek a medication review before starting.

Alcohol does not have a universally stated direct interaction with rifaximin, but drinking can worsen diarrhea, irritate the gut, and contribute to dehydration. For people with liver disease, alcohol can significantly worsen the underlying condition and increase the risk of complications, making avoidance especially important. During treatment for gastrointestinal symptoms, a conservative approach is to limit or avoid alcohol until you are well. If you drink regularly, discuss safe limits with a healthcare professional in Denmark.

Allergic reactions can occur even if you have tolerated other antibiotics in the past. If you have a history of allergy to rifampicin or other rifamycin antibiotics, tell your clinician or pharmacist before taking Xifaxan. Early signs can include rash, itching, or swelling, and severe reactions may involve breathing difficulty. Seek urgent medical care if severe symptoms appear.

Overdose and What to Do in an Emergency

If too much Xifaxan is taken, the likelihood and severity of symptoms can vary by dose and individual factors. Because rifaximin is generally minimally absorbed, systemic toxicity may be less likely than with fully absorbed antibiotics, but overdose can still cause significant gastrointestinal upset or other adverse effects. Do not wait for symptoms to become severe before seeking advice. Keep the packaging available so responders can identify the product strength and batch information.

In Denmark, contact emergency services or a poison information resource if an overdose is suspected, especially in children, older adults, or anyone with severe liver disease. Seek urgent care if there is fainting, severe weakness, trouble breathing, or signs of a serious allergic reaction. If significant vomiting or diarrhea occurs, dehydration risk becomes a priority. Medical professionals can provide supportive care and rule out complications.

If you suspect someone has taken the medicine intentionally or there is a risk of self-harm, treat it as an emergency and seek immediate help. Safe storage, including keeping medicines out of reach of children, reduces accidental ingestion. Avoid transferring tablets into unmarked containers that can lead to dosing mistakes. Proper medication organization is a practical safety measure for households.

Storage, Handling, and Product Quality

Store Xifaxan according to the instructions on the package and patient leaflet. Many tablets are kept at room temperature in a dry place, protected from excess heat and moisture, but you should follow the exact labeled requirements for your pack. Keep the medicine in its original blister packaging until use to protect it from humidity and to preserve identification. Do not use tablets past the expiry date.

Product quality matters particularly for antibiotics. Buy only from pharmacies that provide clear supply-chain information and dispense products with intact packaging and readable labeling. Counterfeit or improperly stored medicines can be ineffective or unsafe. If tablets look unusual, have a strong odor, or packaging appears tampered with, do not use them and contact the supplier.

Dispose of unused or expired antibiotics responsibly. Do not flush medicines unless local guidance explicitly allows it. Many communities offer pharmacy take-back or disposal guidance to prevent environmental contamination and accidental ingestion. Responsible disposal supports both safety and antibiotic stewardship.

Buying Xifaxan Online in Denmark: Prescription, Safety Checks, and Benefits

Many antibiotics, including Xifaxan, are commonly regulated as prescription-only medicines in numerous countries. In Denmark, whether a prescription is required depends on local rules and the specific product authorization, so it should not be assumed that it is available without prescription. A reputable online pharmacy will clearly explain the requirements and may request a valid prescription or provide a structured medical questionnaire review where allowed. If a seller offers antibiotics with no verification at all, that is a potential safety and legality warning sign.

Online purchasing can still offer practical benefits when done through a regulated provider, such as discreet delivery, convenient refills, and access to pharmacist support. Patients managing chronic liver disease may value predictable supply and reminders, while travelers may prefer planning ahead with clear instructions. Look for transparent contact details, clear returns policies where applicable, and professional counseling availability. These features are more meaningful than aggressive marketing claims.

If you plan to buy Xifaxan online, prioritize authentication and patient safety over speed. Confirm the exact brand, strength, and quantity, and ensure you receive a patient leaflet in an understandable language. Check that the pharmacy provides secure payment and protects personal health data. If you have complex conditions or multiple medications, request a pharmacist review before completing the purchase.

Pricing, Alternatives, and How to Order Online With Tracking

Prices for Xifaxan can vary widely across pharmacies in Denmark due to strength, pack size, brand versus generic availability, and supply factors. As an illustrative guide, patients may see a broad range from moderate to high cost compared with many common antibiotics, especially for higher-strength tablets or longer courses. Because prices change, it is best to compare totals based on the full course quantity rather than a single pack. Be cautious with unusually low listings, which can signal non-authorized supply.

Alternatives depend on the condition being treated. For traveler’s diarrhea, management may include oral rehydration and, in selected cases, other antibiotics guided by local resistance patterns and clinical severity. For IBS-D, alternatives can include dietary approaches (for example, structured low-FODMAP guidance), gut-directed antispasmodics, bile acid binders in selected cases, and other prescription options that a clinician may consider. For hepatic encephalopathy, therapy is typically part of a broader plan and should be individualized, often including lactulose and careful management of precipitating factors.

To order Xifaxan from our online pharmacy, follow a safety-first process that aligns with Danish expectations for regulated medicines. Ensure your personal and medical information is accurate so the correct product and counseling can be provided. After dispatch, you should receive shipment confirmation and a tracking reference so you can monitor delivery progress. If tracking does not update within a reasonable time window, contact customer support promptly for carrier verification and delivery assistance.

1. Select the correct Xifaxan strength and pack size for your prescribed course.
2. Complete checkout and provide prescription details or required medical verification where applicable.
3. Confirm delivery address and contact information to avoid carrier delays.
4. Use the provided tracking reference to follow the parcel until delivery.

Frequently Asked Questions

What is Xifaxan used for?

Xifaxan (rifaximin) is an antibiotic that acts mainly in the gut. It is commonly prescribed for conditions such as traveler’s diarrhea caused by certain bacteria, reducing the risk of recurrent hepatic encephalopathy, and irritable bowel syndrome with diarrhea (IBS-D) in appropriate patients. Your prescriber will choose the indication and course based on your diagnosis and medical history.

Is Xifaxan the same as rifaximin?

Rifaximin is the active ingredient, and Xifaxan is a brand name product that contains rifaximin. Different brands may exist depending on the market and local approvals in Denmark. If you are switched between products, confirm the strength and dosing instructions match your prescription.

How quickly does Xifaxan start working?

Many people notice improvement in symptoms within a few days, but the timeline depends on why it was prescribed. For some conditions, the goal is symptom relief; for others (such as hepatic encephalopathy prevention), the benefit may be more about reducing recurrence risk over time. Finish the course exactly as directed unless your clinician tells you to stop.

Does Xifaxan get absorbed into the bloodstream?

Xifaxan is designed to work primarily in the intestines and is minimally absorbed for most people. Because of this, it tends to have fewer whole-body effects than many other antibiotics, but side effects can still occur. Absorption may be higher in certain situations, such as severe liver disease, so follow medical guidance closely.

Can Xifaxan be used for IBS with diarrhea (IBS-D)?

Yes, rifaximin is used in some patients with IBS-D, typically as a time-limited course. Symptoms may improve after treatment, and some people may be considered for repeat courses if symptoms return, depending on local practice and the prescriber’s assessment. It is not a general remedy for all IBS types, so diagnosis matters.

Can I take Xifaxan if I have liver disease?

Xifaxan is often used in people with advanced liver disease to help reduce episodes of hepatic encephalopathy, but dosing and monitoring should be individualized. Tell your prescriber about your full liver history and any recent changes in symptoms. Seek urgent care if you develop confusion, marked drowsiness, or rapidly worsening condition.

What should I do if I miss a dose of Xifaxan?

Take the missed dose as soon as you remember unless it is close to the time of your next dose. If it is nearly time for the next one, skip the missed dose and return to your regular schedule; do not double up. If you miss multiple doses, contact your prescriber or pharmacist for advice.

Can Xifaxan cause diarrhea or C. difficile infection like other antibiotics?

Any antibiotic can disrupt normal gut flora, and antibiotic-associated diarrhea is possible even with medicines that act mainly in the intestines. A more serious concern is C. difficile infection, which can cause persistent or severe watery diarrhea, fever, or abdominal pain. If these occur during or after treatment, seek medical assessment promptly.

Is it safe to take probiotics with Xifaxan?

Some people choose to use probiotics during or after antibiotics, but evidence and optimal timing vary by product and condition. Probiotics are not suitable for everyone (for example, some immunocompromised patients), and they can still cause side effects like bloating. In Denmark, a pharmacist can help you decide whether a specific product is appropriate alongside your prescription.

Can I drink alcohol while taking Xifaxan?

Alcohol is not known to have a specific direct interaction with rifaximin for most people, but it can worsen dehydration and GI symptoms, and it may be unsafe with certain underlying conditions. If Xifaxan is prescribed for liver-related illness, alcohol avoidance is typically important for overall care. When in doubt, ask your prescriber or pharmacist for guidance based on your indication.

How can I buy Xifaxan online safely in Denmark?

If you plan to buy Xifaxan online in Denmark, use a pharmacy that performs appropriate prescription checks, provides access to a pharmacist, and clearly lists contact details and delivery terms. Avoid sites that offer antibiotics without proper medical oversight, as product quality and suitability cannot be assured. Keep your packaging and information leaflet, and contact a healthcare professional if you notice unexpected effects or lack of improvement.

Pharmacist Review

This product page for Xifaxan has been professionally reviewed for pharmacy accuracy, patient-safety relevance, and alignment with typical online pharmacy dispensing checks in Denmark.

As part of this review, key points were checked for clarity and balance, including intended therapeutic use, typical dosing-course concepts, contraindications and precautionary groups, relevant interactions, and practical guidance on what to do if side effects occur or symptoms worsen. Because antibiotics should be used responsibly, the information was also assessed to avoid encouraging inappropriate use and to support safe, prescription-led treatment decisions.

Medical disclaimer: This content is provided for informational purposes only and does not replace advice from a doctor or other qualified healthcare professional. Always follow your prescriber’s instructions and the patient information leaflet supplied with your medicine.

Store Location and Opening Hours

For in-person help with Xifaxan, you can visit our pharmacy at the address below.

Address: Vesterbrogade 6A, 1160 København, Hovedstaden, DK

If you’re planning a pickup, we recommend arriving a little earlier to allow time for advice at the counter.

Produkter fra andre kategorier

• Amoxicillin
• Amoxil
• Vibramycin
• Cipro
• Keflex
• Floxin
• Zithromax
• Furadantin
• Cenmox
• Advent DT
• Flagyl
• Augmentin
• Zyvox
• Seromycin
• Suprax
• Doxycycline
• Omnicef
• Bactrim
• Minocin
• Cefdinir